Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring the role of purinergic receptor P2RY1 in type 2 diabetes risk and pathophysiology: Insights from human functional genomics.
Dance A, Fernandes J, Toussaint B, Vaillant E, Boutry R, Baron M, Loiselle H, Balkau B, Charpentier G, Franc S, Ibberson M, Marre M, Gernay M, Fadeur M, Paquot N, Vaxillaire M, Boissel M, Amanzougarene S, Derhourhi M, Khamis A, Froguel P, Bonnefond A. Dance A, et al. Among authors: balkau b. Mol Metab. 2024 Jan;79:101867. doi: 10.1016/j.molmet.2023.101867. Epub 2023 Dec 28. Mol Metab. 2024. PMID: 38159881 Free PMC article.
Microalbuminuria and markers of the atherosclerotic process: the D.E. S.I.R. study.
Mennen LI, Balkau B, Royer B, Caradec A, Marre M, Balkau B, Eschwège E, Alhenc-Gelas F, Bechetoille A, Gallois Y, Girault A, Marre M, Brochier M, Chesnier MC, Gasnier M, Le Mauff JM, Caradec A, Arondel D, Novak M, Petrella A, D'Hour A, Lépinay P, Royer B, Verstraete N, Aubourg P, Cogneau J, Rougeron C, Diquero V, Cacès E, Cailleau M, Jacquelin JM, Moreau JG, Rakotozafy F, Tichet J, Vol S. Mennen LI, et al. Among authors: balkau b. Atherosclerosis. 2001 Jan;154(1):163-9. doi: 10.1016/s0021-9150(00)00451-2. Atherosclerosis. 2001. PMID: 11137096
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD-REIN cohort study.
Bonnet F, Balkau B, Lambert O, Diawara Y, Combe C, Frimat L, Laville M, Liabeuf S, Massy ZA, Metzger M, Stengel B, Alencar de Pinho N, Fouque D. Bonnet F, et al. Among authors: balkau b. Diabetes Obes Metab. 2024 May;26(5):1908-1918. doi: 10.1111/dom.15507. Epub 2024 Feb 28. Diabetes Obes Metab. 2024. PMID: 38418407
Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.
Folon L, Baron M, Scherrer V, Toussaint B, Vaillant E, Loiselle H, Dechaume A, De Pooter F, Boutry R, Boissel M, Diallo A, Ning L, Balkau B, Charpentier G, Franc S, Marre M, Derhourhi M, Froguel P, Bonnefond A. Folon L, et al. Among authors: balkau b. Diabetes Care. 2024 Mar 1;47(3):444-451. doi: 10.2337/dc23-1851. Diabetes Care. 2024. PMID: 38170957
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.
Meulebrouck S, Scherrer V, Boutry R, Toussaint B, Vaillant E, Dechaume A, Loiselle H, Balkau B, Charpentier G, Franc S, Marre M, Baron M, Vaxillaire M, Derhourhi M, Boissel M, Froguel P, Bonnefond A. Meulebrouck S, et al. Among authors: balkau b. Diabetologia. 2024 Feb;67(2):327-332. doi: 10.1007/s00125-023-06035-x. Epub 2023 Dec 5. Diabetologia. 2024. PMID: 38051360 Free PMC article.
Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity.
Gao W, Liu L, Huh E, Gbahou F, Cecon E, Oshima M, Houzé L, Katsonis P, Hegron A, Fan Z, Hou G, Charpentier G, Boissel M, Derhourhi M, Marre M, Balkau B, Froguel P, Scharfmann R, Lichtarge O, Dam J, Bonnefond A, Liu J, Jockers R. Gao W, et al. Among authors: balkau b. Nat Metab. 2023 Oct;5(10):1673-1684. doi: 10.1038/s42255-023-00889-6. Epub 2023 Sep 14. Nat Metab. 2023. PMID: 37709961
591 results